Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Celldex (CLDX, $23.06): Previewing the Imminent Data Release on Rindopepimut

Note:Comprehensive reports are now available to paid subscribers and can be found in theReportssection.

Investment Background and Thesis
This post is the…
Read more…

Celldex (CLDX, $23.06): Previewing the Imminent Data Release on Rindopepimut

Investment Background and Thesis
In my initial report on Celldex, I highlighted four interesting products that the Company has in development.…
Read more…

Celldex: Why Investors Are So Excited About the Company (CLDX, Hold, $24.39)

This post is an excerpt from the report:Celldex: Pipeline Promise Has Been Embraced by Wall Street

Comprehensive reports are now available…
Read more…

Celldex Initiation Report: Pipeline Promise Has Been Embraced by Wall Street (CLDX, Hold, $22.79)

Review of Amazing and Volatile Stock Price Performance
From the closing price on December 30, 2011 through October 1, 2013 Celldexs…
Read more…